Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Iannotti Buchbinder, M.D.

Concepts (240)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma50202455104.650 Why?
Skin Neoplasms16202456861.510 Why?
Immunotherapy13202444451.110 Why?
Interleukin-24202419040.910 Why?
Proto-Oncogene Proteins B-raf6202320430.780 Why?
Mucous Membrane320236730.740 Why?
Cancer Vaccines4202310230.740 Why?
Antineoplastic Agents102020136950.620 Why?
Antibodies, Monoclonal10202092740.600 Why?
Music Therapy320231020.590 Why?
Molecular Targeted Therapy5201927270.460 Why?
Pyrroles2201711460.430 Why?
Mitogen-Activated Protein Kinase Kinases320236480.410 Why?
T-Lymphocytes, Cytotoxic2201518210.390 Why?
Neoplasms102023216830.380 Why?
Indoles2201618390.370 Why?
Disabled Children120132470.360 Why?
Mutation102023297860.360 Why?
Interferon-alpha120148950.350 Why?
Colitis3202211700.330 Why?
Protein Kinase Inhibitors6202355350.310 Why?
Drug Therapy, Combination4202464890.290 Why?
Drug Resistance, Neoplasm2202051720.270 Why?
Antineoplastic Combined Chemotherapy Protocols102024115240.260 Why?
Humans7120247443430.250 Why?
Neoplasms, Second Primary2202210610.240 Why?
Cytokines2202173220.230 Why?
Carcinoma, Renal Cell1201931430.230 Why?
Immunologic Memory2202113480.220 Why?
Combined Modality Therapy6202386420.220 Why?
Kidney Neoplasms1201942620.210 Why?
Mitogen-Activated Protein Kinases2201712850.200 Why?
Enterocolitis120221020.200 Why?
Antigens, Neoplasm2202119880.190 Why?
Caregivers1201320940.190 Why?
Neoplasm Metastasis6201948510.190 Why?
Gastritis120221960.190 Why?
Angiopoietin-2120211730.190 Why?
Stress, Psychological3202342450.190 Why?
Splenic Neoplasms120211000.190 Why?
Receptors, Vascular Endothelial Growth Factor120246640.180 Why?
Uveal Neoplasms120233100.180 Why?
Lung Neoplasms32023131020.180 Why?
Medical Oncology2202322650.180 Why?
Music120232630.170 Why?
Lymphoma, B-Cell, Marginal Zone120211800.170 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120239030.170 Why?
Colitis, Microscopic12020770.170 Why?
Parents1201334070.170 Why?
Kaplan-Meier Estimate3201965380.160 Why?
MAP Kinase Kinase Kinases220172610.160 Why?
Middle Aged2620232133830.160 Why?
Brain Neoplasms4202188630.150 Why?
Male3320233501180.150 Why?
Carcinoma, Non-Small-Cell Lung1201652210.150 Why?
Radiosurgery2202013290.140 Why?
Antibodies, Blocking120172530.140 Why?
Mitogen-Activated Protein Kinase 3120174800.140 Why?
Cyclin-Dependent Kinase 6120183220.140 Why?
Female3120233801940.140 Why?
Mitogen-Activated Protein Kinase 1120174890.140 Why?
Tumor Escape120183490.130 Why?
Genes, cdc120161160.130 Why?
Encephalitis120194230.130 Why?
Aged2220231632800.130 Why?
Prognosis62022290630.130 Why?
Aged, 80 and over132021577760.130 Why?
Cyclin-Dependent Kinase 4120185380.130 Why?
Immunotherapy, Adoptive1202412700.130 Why?
Chemotherapy, Adjuvant2202334790.130 Why?
Recombinant Fusion Proteins1202437720.130 Why?
Neoplasm Staging92023110310.120 Why?
Thyroid Diseases120173790.120 Why?
Epitopes1202125710.120 Why?
Herpesvirus 4, Human1201910410.120 Why?
Aminopyridines120175420.120 Why?
Antirheumatic Agents1202313390.120 Why?
Immunomodulation120175410.120 Why?
Hydroxamic Acids120164940.110 Why?
Creatinine1201919190.110 Why?
Adjuvants, Immunologic3202410000.110 Why?
Nevus, Pigmented120152190.110 Why?
Young Adult112023564300.110 Why?
Publishing120208330.110 Why?
Retrospective Studies172023774490.110 Why?
Neoplasm Recurrence, Local4202392390.110 Why?
Mental Disorders1201366000.110 Why?
Adult2120232140550.110 Why?
Radiation Injuries1202011800.110 Why?
Neoadjuvant Therapy1202327280.100 Why?
Clinical Trials, Phase III as Topic120168410.100 Why?
Adrenal Cortex Hormones1202118550.100 Why?
Lymphoma1202118770.100 Why?
Clinical Trials as Topic2202079130.100 Why?
Survival Analysis52019102520.100 Why?
Survival Rate32021127880.100 Why?
Proto-Oncogene Proteins c-kit120157760.100 Why?
Histone Deacetylase Inhibitors120167890.100 Why?
Thromboplastin120122910.100 Why?
Enoxaparin120123770.090 Why?
Israel120137960.090 Why?
Sarcoma1202118970.090 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202115960.090 Why?
CD4-Positive T-Lymphocytes2201943860.090 Why?
Radiation-Sensitizing Agents120113580.080 Why?
Oximes220233110.080 Why?
Lymphocyte Activation1201955240.080 Why?
Arthritis, Rheumatoid1202337120.080 Why?
Autoimmunity1201613490.080 Why?
Pyrimidinones220233710.080 Why?
Deoxycytidine120118260.070 Why?
Interferons120107060.070 Why?
Adolescent72023857810.070 Why?
Vitamin D1202032230.070 Why?
Neoplasm Proteins1201937030.070 Why?
Thromboembolism120129860.070 Why?
Treatment Outcome72017631140.070 Why?
DNA Mutational Analysis1201441860.070 Why?
Cell Transformation, Neoplastic1201529420.060 Why?
Inflammatory Bowel Diseases1202024250.060 Why?
Pyridones220237120.060 Why?
Quality of Life22023128040.060 Why?
Gene Expression Profiling1202094380.060 Why?
Follow-Up Studies32021390500.060 Why?
Autoimmune Diseases1201621330.060 Why?
Cohort Studies32022405610.060 Why?
Inflammation12023106380.060 Why?
Colorectal Neoplasms1202367730.060 Why?
Practice Guidelines as Topic1202072790.060 Why?
Leukocytes, Mononuclear2202418360.050 Why?
Adaptation, Psychological1201325760.050 Why?
Dose-Response Relationship, Drug12014109430.050 Why?
Cell Line, Tumor42020166890.050 Why?
New York120238860.050 Why?
T-Lymphocytes12018101800.050 Why?
Disease Progression32023132840.050 Why?
Antigens, CD1201040260.040 Why?
Consensus Development Conferences as Topic120201700.040 Why?
Guanine Nucleotide Exchange Factors120035810.040 Why?
Tumor Microenvironment2202135860.040 Why?
RNA, Double-Stranded120202900.040 Why?
Taxoids120216660.040 Why?
Animals520201687570.040 Why?
Anxiety2202342970.040 Why?
HeLa Cells2202031280.040 Why?
Authorship120202710.040 Why?
Signal Transduction22016234030.040 Why?
Anticoagulants1201245990.040 Why?
Thyrotoxicosis12017820.040 Why?
Mutagenesis, Site-Directed1202017230.040 Why?
Obesity12019127450.040 Why?
Abdominal Pain1202210630.030 Why?
Sentinel Lymph Node Biopsy120207090.030 Why?
Necrosis1202016430.030 Why?
Drug Administration Schedule2201649330.030 Why?
Proportional Hazards Models22021123540.030 Why?
Research Personnel120205730.030 Why?
Diarrhea1202213480.030 Why?
GTP-Binding Protein alpha Subunits, Gq-G11120151400.030 Why?
Retreatment120166100.030 Why?
Child32023777090.030 Why?
Cranial Irradiation120174010.030 Why?
History, 21st Century1202015340.030 Why?
Immunologic Factors1202315800.030 Why?
Qualitative Research1202326820.030 Why?
High-Throughput Nucleotide Sequencing2201735970.030 Why?
Phosphoproteins1200324400.030 Why?
Receptors, Immunologic1202014230.030 Why?
Drosophila Proteins1200317030.030 Why?
Pancreatic Neoplasms1201152560.030 Why?
Protein-Tyrosine Kinases1200324550.030 Why?
Monocytes1202325960.030 Why?
Glucocorticoids1202221070.030 Why?
Pandemics2202383880.030 Why?
Histocompatibility Antigens Class II1201714750.030 Why?
Codon120146110.030 Why?
Vascular Endothelial Growth Factor A1202435080.030 Why?
Hypothyroidism120176580.030 Why?
History, 20th Century1202027400.030 Why?
Ubiquitin Thiolesterase120154490.030 Why?
Lymphocytes1202026170.030 Why?
Melanocytes120155150.030 Why?
Feasibility Studies1202150780.030 Why?
Tumor Burden1201719150.020 Why?
Consensus1202029590.020 Why?
CA-19-9 Antigen120111110.020 Why?
Polymorphism, Single Nucleotide12010155190.020 Why?
Cell-Derived Microparticles120121680.020 Why?
Fibrin Fibrinogen Degradation Products120124260.020 Why?
Imidazoles1201612060.020 Why?
Proteomics1202336380.020 Why?
Amino Acid Substitution1201417910.020 Why?
Pneumonia1202121330.020 Why?
Pilot Projects1202183240.020 Why?
Macrophages1202356550.020 Why?
Risk Assessment22022233380.020 Why?
Neutrophils1202037190.020 Why?
DNA Primers1201028920.020 Why?
Sequence Analysis, DNA1201748030.020 Why?
Amino Acid Sequence12017138150.020 Why?
Tumor Suppressor Proteins1201528490.020 Why?
Sex Factors12019103970.020 Why?
Research Design1202059870.020 Why?
Radiotherapy Dosage1201128790.020 Why?
Mice32020811830.020 Why?
Tomography, X-Ray Computed22017201290.020 Why?
Gene Expression Regulation, Neoplastic1202084280.010 Why?
Randomized Controlled Trials as Topic1202099590.010 Why?
CD8-Positive T-Lymphocytes1201744790.010 Why?
Patient Selection1201642150.010 Why?
Gene Frequency1201035880.010 Why?
Risk Factors22023722900.010 Why?
Focal Adhesion Kinase 1120031200.010 Why?
Radiotherapy Planning, Computer-Assisted1201116240.010 Why?
Focal Adhesion Protein-Tyrosine Kinases120031820.010 Why?
src Homology Domains120033640.010 Why?
Body Mass Index12019127200.010 Why?
Disease Models, Animal12020180290.010 Why?
Polymerase Chain Reaction1201061710.010 Why?
COS Cells1200311610.010 Why?
Mice, Inbred C57BL12018218270.010 Why?
Algorithms12020138810.010 Why?
Genotype12014129510.010 Why?
Magnetic Resonance Imaging22017354210.010 Why?
Sensitivity and Specificity12014147220.010 Why?
Base Sequence12010127970.010 Why?
Mutagenesis1200312660.010 Why?
Sequence Deletion1200315260.010 Why?
Reproducibility of Results12014199050.010 Why?
Prospective Studies12020532880.010 Why?
Drosophila1200314910.010 Why?
Transfection1200358920.010 Why?
Time Factors12016400750.010 Why?
Binding Sites1200361140.010 Why?
Caenorhabditis elegans1200314190.010 Why?
Genetic Predisposition to Disease12015174460.010 Why?
Recombinant Proteins1200366220.010 Why?
Case-Control Studies12010217460.010 Why?
Phosphorylation1200384360.010 Why?
Muscle, Skeletal1200349310.000 Why?
Buchbinder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (240)
Explore
_
Co-Authors (123)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.